a few people working at a table

Press Releases

Ladenburg Thalmann acts as Lead Bookrunner for Carlyle Credit Income Fund on its Series A Term Preferred Offering of $30 Million

Ladenburg Thalmann served as Lead Bookrunner for this offering. Since 2017, Ladenburg has led 53 fixed income...

Ladenburg Acts as Exclusive Placement Agent in $28 Million Private Placement for enVVeno Medical

Transaction Information enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company") announced that...

Ladenburg Thalmann Acts as Sole Book-Running Manager in $4.378 Million Underwritten Public Offering for Intelligent Bio Solutions Inc.

Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company") announced the closing of...

Ladenburg Thalmann Acts as Joint Book-Running Manager for Sonnet BioTherapeutics in its $4.55 Million Follow-On Offering

Transaction Information Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) announced the closing of a follow-on...

Ladenburg Thalmann Acts as Exclusive Placement Agent in $2 Million Private Placement for Coeptis Therapeutics

Transaction Information Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company") announced...

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Ocular Therapeutix, Inc. (Nasdaq: OCUL) in its $82.5 Million Non-Dilutive Financing

Transaction Information Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular Therapeutix", or "the Company), a...

Ladenburg Thalmann acts as Lead Bookrunner for Eagle Point Income Company, Inc. on its Term Preferred Offering of $28 Million

Ladenburg Thalmann served as Lead Bookrunner for this offering. Since 2017, Ladenburg has led 52 fixed income...

Ladenburg Thalmann Acts as Co-Manager for Harrow in its $60.0 Million Public Offering

Transaction Information Harrow Health, Inc. (NASDAQ: HROW) priced an underwritten registered public offering of...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Kiora Pharmaceuticals, Inc. in its $6.3 Million Underwritten Public Offering

Transaction Information Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced the closing of an underwritten...